← Browse by Condition
Medical Condition
metastatic melanoma
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 1
NCT07281924 Phase 1, Phase 2
Recruiting
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Enrollment
15 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
NCT05026983 Phase 2
Recruiting
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
Enrollment
35 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06887348
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Enrollment
50 pts
Location
United States, Austr...
Sponsor
Replimune Inc.
NCT07288203 Phase 2
Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Enrollment
100 pts
Location
United States, Austr...
Sponsor
Iovance Biotherapeutics, Inc.
NCT04119024 Phase 1
Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi
NCT05779423 Phase 2
Recruiting
Cryoablation+Ipilimumab+Nivolumab in Melanoma
Enrollment
37 pts
Location
United States
Sponsor
Massachusetts General Hospital